- Home
- COCH vs IOBT Comparison
COCH vs IOBT Comparison
Compare COCH & IOBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COCH
- IOBT
- Stock Information
- Founded
- COCH 1995
- IOBT 2014
- Country
- COCH United States
- IOBT Denmark
- Employees
- COCH N/A
- IOBT N/A
- Industry
- COCH Blank Checks
- IOBT Biotechnology: Pharmaceutical Preparations
- Sector
- COCH Finance
- IOBT Health Care
- Exchange
- COCH Nasdaq
- IOBT Nasdaq
- Market Cap
- COCH 64.4M
- IOBT 56.7M
- IPO Year
- COCH N/A
- IOBT 2021
- Fundamental
- Price
- COCH $1.84
- IOBT $0.77
- Analyst Decision
- COCH Strong Buy
- IOBT Strong Buy
- Analyst Count
- COCH 4
- IOBT 3
- Target Price
- COCH $8.00
- IOBT $9.33
- AVG Volume (30 Days)
- COCH 42.8K
- IOBT 629.4K
- Earning Date
- COCH 11-14-2024
- IOBT 11-12-2024
- Dividend Yield
- COCH N/A
- IOBT N/A
- EPS Growth
- COCH N/A
- IOBT N/A
- EPS
- COCH N/A
- IOBT N/A
- Revenue
- COCH $278,000.00
- IOBT N/A
- Revenue This Year
- COCH N/A
- IOBT N/A
- Revenue Next Year
- COCH $17.09
- IOBT N/A
- P/E Ratio
- COCH N/A
- IOBT N/A
- Revenue Growth
- COCH 15.35
- IOBT N/A
- 52 Week Low
- COCH $1.08
- IOBT $0.66
- 52 Week High
- COCH $11.46
- IOBT $2.10
- Technical
- Relative Strength Index (RSI)
- COCH 38.78
- IOBT 38.48
- Support Level
- COCH $1.64
- IOBT $0.75
- Resistance Level
- COCH $2.06
- IOBT $0.84
- Average True Range (ATR)
- COCH 0.20
- IOBT 0.07
- MACD
- COCH -0.02
- IOBT 0.00
- Stochastic Oscillator
- COCH 38.24
- IOBT 16.90
About COCH Envoy Medical Inc.
Envoy Medical Inc is a hearing health company focused on providing innovative medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life.
About IOBT IO Biotech Inc.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.